Gga-miR-219b Targeting BCL11B Suppresses Proliferation, Migration and Invasion of Marek's Disease Tumor Cell MSB1

Overview

Journal Sci Rep

Specialty Science

Date 2017 Jun 28

PMID 28652615

Citations 14

Authors

Chunfang Zhao

Xin Li

Bo Han

Zhen You

Lujiang Qu

Changjun Liu

Jiuzhou Song

Ling Lian

Ning Yang

Affiliations

Soon will be listed here.

Abstract

Marek's disease (MD), caused by Marek's disease virus (MDV), is a lymphotropic neoplastic disease. Previous miRNAome analysis showed gga-miR-219b was significantly downregulated in MDV-induced lymphoma, and one of its potential target genes, B-cell chronic lymphocytic /lymphoma 11B (BCL11B) was predicted. In this study, we further investigated the function of gga-miR-219b, and the gain/loss of function assay showed gga-miR-219b inhibited cell migration and reduced cell proliferation by promoting apoptosis not by cell cycle arrest. Gga-miR-219b also suppressed expression of two cell invasion-related genes MMP2 and MMP9. The results indicated suppressive effect of gga-miR-219b on MD tumorigenesis. The gene BCL11B was verified as a direct target gene of gga-miR-219b. RNA interference was performed to block BCL11B. As expected, the effects triggered by BCL11B downregulation were in accordance with that triggered by gga-miR-219b overexpression, suggesting that BCL11B was a stimulative regulator of MD transformation. Moreover, both gga-miR-219b and BCL11B influenced the expression of Meq gene, the most important oncogene in MDV. Additionally, gene expression level of anti-apoptotic genes BCL2 and BCL2L1 was downregulated and pro-apoptotic gene TNFSF10 was upregulated in MSB1 cells with gga-miR-219b overexpression or BCL11B knockdown, which suggested gga-miR-219b promoted cell apoptosis via regulating gene expression in the apoptosis pathways.

Citing Articles

Analysis of the Transcriptional Control of in Chicken: IRF1 and GATA1 as Negative Regulators.

Qiu L, Wang H, Li W, Yang T, Bai H, Chang G Animals (Basel). 2025; 15(5).

PMID: 40075948 PMC: 11898421. DOI: 10.3390/ani15050665.

Characterization of microRNA candidates at the primary site of infectious bronchitis virus infection: A comparative study of in vitro and in vivo avian models.

ODowd K, Vatandour S, Ahamed S, Boulianne M, Dozois C, Gagnon C PLoS One. 2025; 20(3):e0319153.

PMID: 40067877 PMC: 11896067. DOI: 10.1371/journal.pone.0319153.

MicroRNAs: exploring their role in farm animal disease and mycotoxin challenges.

Kappari L, Dasireddy J, Applegate T, Selvaraj R, Shanmugasundaram R Front Vet Sci. 2024; 11:1372961.

PMID: 38803799 PMC: 11129562. DOI: 10.3389/fvets.2024.1372961.

Regulation of Wnt/β-catenin signaling by Marek's disease virus and .

Xu H, Xu X, He H, Shao H, Yao Y, Qin A Front Microbiol. 2024; 15:1388862.

PMID: 38638910 PMC: 11025357. DOI: 10.3389/fmicb.2024.1388862.

Critical roles of non-coding RNAs in lifecycle and biology of Marek's disease herpesvirus.

Teng M, Zhu Z, Yao Y, Nair V, Zhang G, Luo J Sci China Life Sci. 2023; 66(2):251-268.

PMID: 36617590 PMC: 9838510. DOI: 10.1007/s11427-022-2258-4.

References

Yao Y, Zhao Y, Smith L, Lawrie C, Saunders N, Watson M . Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J Gen Virol. 2009; 90(Pt 7):1551-1559. DOI: 10.1099/vir.0.009902-0. View

Subramaniam S, Johnston J, Preeyanon L, Brown C, Kung H, Cheng H . Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq. J Virol. 2013; 87(16):9016-29. PMC: 3754031. DOI: 10.1128/JVI.01163-13. View

Lahdaoui F, Delpu Y, Vincent A, Renaud F, Messager M, Duchene B . miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer. Oncogene. 2014; 34(6):780-8. DOI: 10.1038/onc.2014.11. View

Cismasiu V, Ghanta S, Duque J, Albu D, Chen H, Kasturi R . BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes. Blood. 2006; 108(8):2695-702. PMC: 1895584. DOI: 10.1182/blood-2006-05-021790. View

Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen S, Zhang J . The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood. 2011; 118(15):4169-73. PMC: 3204734. DOI: 10.1182/blood-2010-11-318873. View

Gao W, Kondo Y, Shen L, Shimizu Y, Sano T, Yamao K . Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis. 2008; 29(10):1901-10. DOI: 10.1093/carcin/bgn170. View

Rao S, Arimappamagan A, Pandey P, Santosh V, Hegde A, Chandramouli B . miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma. PLoS One. 2013; 8(5):e63164. PMC: 3656853. DOI: 10.1371/journal.pone.0063164. View

Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y . Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol. 2003; 4(6):533-9. DOI: 10.1038/ni927. View

Kuribayashi K, Krigsfeld G, Wang W, Xu J, Mayes P, Dicker D . TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death. Cancer Biol Ther. 2008; 7(12):2034-8. DOI: 10.4161/cbt.7.12.7460. View

10.

Bhattacharya S, Garrison J, Guo H, Mi Z, Markovic J, Kim V . Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines. Surgery. 2010; 148(2):291-7. PMC: 2905491. DOI: 10.1016/j.surg.2010.05.007. View

11.

Favreau A, Sathyanarayana P . miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia. Leuk Res. 2011; 36(3):334-41. PMC: 3264807. DOI: 10.1016/j.leukres.2011.09.027. View

12.

Brennecke J, Stark A, Russell R, Cohen S . Principles of microRNA-target recognition. PLoS Biol. 2005; 3(3):e85. PMC: 1043860. DOI: 10.1371/journal.pbio.0030085. View

13.

Hayes J, Peruzzi P, Lawler S . MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014; 20(8):460-9. DOI: 10.1016/j.molmed.2014.06.005. View

14.

Kung H, Tanaka A, Nonoyama M . 2 gene families of mareks-disease virus (mdv) with a potential role in tumor-induction in chicken (review). Int J Oncol. 2011; 6(5):997-1002. DOI: 10.3892/ijo.6.5.997. View

15.

Di Leva G, Garofalo M, Croce C . MicroRNAs in cancer. Annu Rev Pathol. 2013; 9:287-314. PMC: 4009396. DOI: 10.1146/annurev-pathol-012513-104715. View

16.

Burgess S, Young J, Baaten B, Hunt L, Ross L, Parcells M . Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc Natl Acad Sci U S A. 2004; 101(38):13879-84. PMC: 518847. DOI: 10.1073/pnas.0305789101. View

17.

Li C, Nie H, Wang M, Su L, Li J, Yu B . MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett. 2012; 320(2):189-97. DOI: 10.1016/j.canlet.2012.02.030. View

18.

Qian Z, Brunovskis P, Lee L, Vogt P, Kung H . Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J Virol. 1996; 70(10):7161-70. PMC: 190769. DOI: 10.1128/JVI.70.10.7161-7170.1996. View

19.

Dubuissez M, Loison I, Paget S, Vorng H, Ait-Yahia S, Rohr O . Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation. Mol Cell Biol. 2016; 36(13):1881-98. PMC: 4911745. DOI: 10.1128/MCB.00062-16. View

20.

Lian L, Li X, Zhao C, Han B, Qu L, Song J . Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line. Poult Sci. 2015; 94(11):2616-21. DOI: 10.3382/ps/pev289. View